CTO Realty's properties in high-growth sunbelt markets benefit from strong demand and limited supply. Read how CTO is well-positioned for robust long-term growth.

The Senate is finding itself in a familiar position, working to avoid a partial government shutdown with just hours to spare ...

In 2025, Cellectis will continue to focus its efforts and expenses on advancing its core clinical trials BALLI-01 and NATHALI-01, while building the next generation of genomic medicines to address ...